UB Paderborn / Katalog / Suche / in CDI

Expression of the immune checkpoint VISTA in breast cancer

Cancer Immunology, Immunotherapy, 2020-08, Vol.69 (8), p.1437-1446

2020

Volltextzugriff (PDF)

Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer

Modern pathology, 2022-02, Vol.35 (2), p.266-273

2022

Volltextzugriff (PDF)

The significance of an immunohistochemical marker-based panel in assisting the diagnosis of parathyroid carcinoma

Endocrine, 2024, Vol.84 (3), p.1146-1153

2024

Volltextzugriff (PDF)

Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma

Frontiers in immunology, 2022-10, Vol.13, p.1027459-1027459

2022

Volltextzugriff (PDF)

Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma

Frontiers in immunology, 2022-07, Vol.13, p.942154-942154

2022

Volltextzugriff (PDF)

Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications

Endocrine, 2022-09, Vol.77 (3), p.538-545

2022

Volltextzugriff (PDF)

Correction to: Expression of the immune checkpoint VISTA in breast cancer

Cancer Immunology, Immunotherapy, 2020-08, Vol.69 (8), p.1447-1447

2020

Volltextzugriff (PDF)

De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients

BMC women's health, 2023-03, Vol.23 (1), p.141-141, Article 141

2023

Volltextzugriff (PDF)

Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma

The journal of pathology. Clinical research, 2022-05, Vol.8 (3), p.268-278

2022

Volltextzugriff (PDF)

Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas

Journal of clinical medicine, 2023-01, Vol.12 (2), p.530

2023

Volltextzugriff (PDF)

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules

The journal of pathology. Clinical research, 2022-05, Vol.8 (3), p.257-267

2022

Volltextzugriff (PDF)

Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosis

Rheumatic & musculoskeletal diseases open, 2022-09, Vol.8 (2), p.e002521

2022

Volltextzugriff (PDF)

Expression of PD-L1 and VISTA in Intraductal Papillary Mucinous Neoplasm With Associated Invasive Carcinoma of the Pancreas

Modern pathology, 2023-09, Vol.36 (9), p.100223-100223, Article 100223

2023

Volltextzugriff (PDF)

PD-L1 expression in tumor cells is associated with a favorable prognosis in patients with high-risk endometrial cancer

Gynecologic oncology, 2021-09, Vol.162 (3), p.631-637

2021

Volltextzugriff (PDF)

Expression of B7 family checkpoint proteins in cervical cancer

Modern pathology, 2022-06, Vol.35 (6), p.786-793

2022

Volltextzugriff (PDF)

B7-H4 Further Stratifies Patients With Endometrial Cancer Exhibiting a Nonspecific Molecular Profile

Archives of pathology & laboratory medicine (1976), 2023-11, Vol.147 (11), p.1288-1297

2023

Volltextzugriff (PDF)

The tumoral microbiome of pancreatic intraductal papillary mucinous neoplasm: A single‐center retrospective cohort study

Journal of gastroenterology and hepatology, 2024-03, Vol.39 (3), p.496-505

2024

Volltextzugriff (PDF)

Prognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node-Negative, p53-Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma

Archives of pathology & laboratory medicine (1976), 2023-04, Vol.147 (4), p.465-473

2023

Volltextzugriff (PDF)

High Mast Cell Density Predicts a Favorable Prognosis in Patients with Pancreatic Neuroendocrine Neoplasms

Neuroendocrinology, 2022-08, Vol.112 (9), p.845-855

2022

Volltextzugriff (PDF)

Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors

Archives of pathology & laboratory medicine (1976), 2023-02, Vol.147 (2), p.193-201

2023

Volltextzugriff (PDF)

A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms

Neuroendocrinology, 2022-11, Vol.112 (12), p.1187-1199

2022

Volltextzugriff (PDF)

Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma

Cell death and differentiation, 2023-08, Vol.30 (8), p.1988-2004

2023

Volltextzugriff (PDF)

Clinicopathological analysis of patients with molecularly confirmed stage I adult granulosa cell tumors and prediction of recurrence

Gynecologic oncology, 2023-09, Vol.176, p.106-114

2023

Volltextzugriff (PDF)

The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma

Theranostics, 2023-01, Vol.13 (13), p.4601-4614

2023

Volltextzugriff (PDF)

Alternative Lengthening of Telomeres Phenotype Predicts Progression Risk in Noninsulinomas in a Chinese Cohort

Neuroendocrinology, 2022-05, Vol.112 (5), p.510-522

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Expression of the immune checkpoint VISTA in breast cancer

Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer

The significance of an immunohistochemical marker-based panel in assisting the diagnosis of parathyroid carcinoma

Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma

Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma

Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications

Correction to: Expression of the immune checkpoint VISTA in breast cancer

De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients

Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma

Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules

Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosis

Expression of PD-L1 and VISTA in Intraductal Papillary Mucinous Neoplasm With Associated Invasive Carcinoma of the Pancreas

PD-L1 expression in tumor cells is associated with a favorable prognosis in patients with high-risk endometrial cancer

Expression of B7 family checkpoint proteins in cervical cancer

B7-H4 Further Stratifies Patients With Endometrial Cancer Exhibiting a Nonspecific Molecular Profile

The tumoral microbiome of pancreatic intraductal papillary mucinous neoplasm: A single‐center retrospective cohort study

Prognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node-Negative, p53-Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma

High Mast Cell Density Predicts a Favorable Prognosis in Patients with Pancreatic Neuroendocrine Neoplasms

Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors

A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms

Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma

Clinicopathological analysis of patients with molecularly confirmed stage I adult granulosa cell tumors and prediction of recurrence

The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma

Alternative Lengthening of Telomeres Phenotype Predicts Progression Risk in Noninsulinomas in a Chinese Cohort

Suchergebnisse filtern